The Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS) is the principal government-funded system for reporting adverse vaccine reactions in the U.S. New data for this week, shows a total of 1,307,928 reports of adverse events following COVID-19 vaccines were submitted between December 14, 2020, and June 17, 2022, an increase of 6,572 adverse events over last week. This includes a total of 29,031 reports of deaths — an increase of 172 over last week — and 240,022 serious injuries, including deaths, during the same time period — an increase of 1,610 compared with last week. Of the 29,031 reported deaths, 18,814 cases were from Pfizer’s Covid-19 vaccine, 7,627 cases to Moderna and 2,525 cases to Johnson & Johnson (J&J)
“The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,307,928 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and June 17, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 6,572 adverse events over the previous week.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 29,031 reports of deaths — an increase of 172 over the previous week — and 240,022 serious injuries, including deaths, during the same time period — up 1,610 compared with the previous week.
Of the 29,031 reported deaths, 18,814 cases are attributed to Pfizer’s COVID-19 vaccine, 7,627 cases to Moderna and 2,525 cases to Johnson & Johnson (J&J).
Excluding “foreign reports” to VAERS, 835,063 adverse events, including 13,388 deaths and 84,542 serious injuries, were reported in the U.S. between Dec. 14, 2020, and June 17, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 13,388 U.S. deaths reported as of June 17, 16% occurred within 24 hours of vaccination, 20% occurred within 48 hours of vaccination and 59% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 592 million COVID-19 vaccine doses had been administered as of June 16, including 349 million doses of Pfizer, 223 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to June 17, 2022, for 6-month-olds to 5-year-olds show:
- 1,757 adverse events, including 64 cases rated as seriousand 3 reported deaths.
- 4 reportsof myocarditis and pericarditis (heart inflammation).
- The CDC uses a narrowed case definitionof “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 13 reportsof blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 17, 2022, for 5- to 11-year-olds show:
- 11,534 adverse events, including 298 rated as serious and 6 reported deaths.
The most recent reported death (VAERS I.D. 2315376) occurred in a 9-year-old female from Florida who died 172 days after receiving Pfizer’s vaccine. She was diagnosed with COVID-19 on May 28, 2022, and treated with various drugs, including Remdesivir. She was found unresponsive at home on June 3, and was declared brain dead.
- 22 reportsof myocarditis and pericarditis.
The Defender has noticed over previous weeks that reports of myocarditis and pericarditis have been removed by the CDC from the VAERS system in this age group. No explanation was provided.
- 44 reportsof blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 17, 2022, for 12- to 17-year-olds show:
- 32,386 adverse events, including 1,834 rated as seriousand 44 reported deaths.
- 62 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
- 655 reportsof myocarditis and pericarditis with 643 cases attributed to Pfizer’s vaccine.
- 166 reportsof blood clotting disorders with all cases attributed to Pfizer. VAERS reported 167 cases of blood clotting disorders in the 12- to 17-year-old age group last week.
- 20 casesof postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.
U.S. VAERS data from Dec. 14, 2020, to June 17, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 53% of those who died were male, 42% were female and the remaining death reports did not include the gender of the deceased.
- The average ageof death was 73.
- As of June 17, 5,592 pregnant womenreported adverse events related to COVID-19 vaccines, including 1,748 reports of miscarriage or premature birth.
- Of the 3,614 cases of Bell’s Palsyreported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 892 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Modernaand 27% to J&J.
- 2,290 reportsof anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,726 reportsof myocardial infarction.
- 14,118 reportsof blood-clotting disorders in the U.S. Of those, 6,313 reports were attributed to Pfizer, 5,065 reports to Moderna and 2,703 reports to J&J.
- 4,060 casesof myocarditis and pericarditis with 2,596 cases attributed to Pfizer, 1,441 cases to Moderna and 172 cases to J&J.
- 11 casesof Creutzfeldt-Jakob disease with 5 cases attributed Pfizer, 5 cases to Moderna and 1 case to J&J.
- 267 casesof POTS with 165 cases attributed to Pfizer, 84 cases to Moderna and 17 cases to J&J.”